Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.

Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K.

Drug Alcohol Depend. 2002 May 1;66(3):283-93.

PMID:
12062463
2.

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD.

Am J Med. 2001 Jun 1;110(8):610-5.

PMID:
11382368
3.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
4.

Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance.

O'Connor PG, Shi JM, Henry S, Durante AJ, Friedman L, Selwyn PA.

Addiction. 1999 Jul;94(7):1071-5.

PMID:
10707445
5.
6.

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.

Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD.

AIDS. 1998 Dec 24;12(18):2447-57.

PMID:
9875583
7.

Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.

Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.

Clin Infect Dis. 2003 Dec 15;37(12):1686-92. Epub 2003 Nov 17.

8.

Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.

Gourevitch MN, Alcabes P, Wasserman WC, Arno PS.

Int J Tuberc Lung Dis. 1998 Jul;2(7):531-40.

PMID:
9661818
9.

Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco.

White MC, Gournis E, Kawamura M, Menendez E, Tulsky JP.

Int J Tuberc Lung Dis. 2003 Jan;7(1):30-5.

PMID:
12701832
10.

Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.

Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, Guleria S, Mehta SN.

Transpl Infect Dis. 2005 Sep-Dec;7(3-4):99-108.

PMID:
16390397
11.

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.

King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK.

J Subst Abuse Treat. 2006 Dec;31(4):385-93. Epub 2006 Aug 14.

PMID:
17084792
12.

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.

Gourevitch MN, Hartel D, Selwyn PA, Schoenbaum EE, Klein RS.

AIDS. 1999 Oct 22;13(15):2069-74.

PMID:
10546859
13.

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

Johnson JL, Okwera A, Hom DL, Mayanja H, Mutuluuza Kityo C, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC; Uganda-Case Western Reserve University Research Collaboration.

AIDS. 2001 Nov 9;15(16):2137-47.

PMID:
11684933
14.

Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.

Mohammed A, Myer L, Ehrlich R, Wood R, Cilliers F, Maartens G.

Int J Tuberc Lung Dis. 2007 Oct;11(10):1114-20.

PMID:
17945069
16.

Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Dar es Salaam.

Bakari M, Moshi A, Aris EA, Chale S, Josiah R, Magao P, Pallangyo N, Mugusi F, Sandström E, Biberfeld G, Mhalu F, Pallangyo K.

East Afr Med J. 2000 Sep;77(9):494-7.

PMID:
12862141
17.

Use of mental health and substance abuse treatment services by female injection drug users.

Amodeo M, Chassler D, Ferguson F, Fitzgerald T, Lundgren L.

Am J Drug Alcohol Abuse. 2004;30(1):101-20.

PMID:
15083556
18.

Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.

Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP.

Int J Tuberc Lung Dis. 2006 Oct;10(10):1080-90.

PMID:
17044199
19.

Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.

Gourevitch MN, Wasserman W, Panero MS, Selwyn PA.

J Addict Dis. 1996;15(1):93-104.

PMID:
8729149
20.

[Preventive therapy in middle-aged and elderly persons selected from the population-based screening by mass miniature radiography--methodological aspect and adverse reactions].

Ohmori M, Wada M, Nishii K, Nakazono T, Masuyama H, Yoshiyama T, Inaba K, Itoh K, Uchimura K, Saegusa M, Mitarai S, Kimura M, Shimouchi A.

Kekkaku. 2002 Oct;77(10):647-58. Japanese.

PMID:
12440139
Items per page

Supplemental Content

Write to the Help Desk